ME had 510 confirmed influenza cases through January 5 - the latest figures available - down from 768 during the same time period in 2017-18.
"Since 2009, the H1N1 strain has reappeared as the dominant strain circulating during several flu seasons (2013-2014 and 2015-2016)".
"If you haven't had your flu shot yet, you should run, not walk, to go get your flu shot", said Dr. Kolawole Bankole, director/administrator of Portland Public Health. These tests are rapid, like the name suggests but depending on the actual strain of the virus going around they can have varying success in properly identifying the flu.More news: Broncos choosing between Fangio, Munchak for HC job
More news: Nvidia introduces GeForce RTX 2060, 6GB of G6 memory for $349
More news: Healthcare facility’s CEO resigns after woman in coma for decade gives birth
According to this week's CDC FluView report, high influenza activity has been seen in 19 states plus New York City with two flu-associated pediatric deaths reported. The flu vaccine can not give persons the flu, but may cause one to develop flu-like symptoms. With a little commitment to these health techniques and vaccination, we can prevent and treat this public health problem.
"If you are a business owner, you should also encourage your employees to get vaccinated". You can stay healthy this season for those children and elderly individuals in your life who are more at-risk for becoming critically ill if you pass the virus on to them.
Symptoms of the flu include fever, chills, muscle aches, cough, congestion, runny nose, headaches and fatigue. They are reminding people to wash their hands frequently, cover their coughs and sneezes with arms, not hands, clean frequently touched surfaces and keep a distance from others to avoid spreading the flu. Children as young as 6 months old can get a flu shot. When it is cold outside, people tend to stay inside and are more likely to spread germs to one another.
What Really Makes You Sick? . The flu, on the other hand, is caused by the influenza virus.
hVIVO plc, announced positive results for the primary endpoint, following completion of the analysis of samples by National Institute of Allergy and Infectious Diseases (NIAID) and additional results from the Phase IIb viral challenge study of FLU-v.